全文获取类型
收费全文 | 1211篇 |
免费 | 117篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 40篇 |
妇产科学 | 44篇 |
基础医学 | 145篇 |
口腔科学 | 41篇 |
临床医学 | 97篇 |
内科学 | 348篇 |
皮肤病学 | 44篇 |
神经病学 | 61篇 |
特种医学 | 29篇 |
外科学 | 159篇 |
综合类 | 9篇 |
预防医学 | 56篇 |
眼科学 | 8篇 |
药学 | 104篇 |
中国医学 | 6篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 21篇 |
2022年 | 22篇 |
2021年 | 45篇 |
2020年 | 35篇 |
2019年 | 48篇 |
2018年 | 44篇 |
2017年 | 36篇 |
2016年 | 41篇 |
2015年 | 53篇 |
2014年 | 52篇 |
2013年 | 65篇 |
2012年 | 97篇 |
2011年 | 104篇 |
2010年 | 61篇 |
2009年 | 48篇 |
2008年 | 73篇 |
2007年 | 58篇 |
2006年 | 47篇 |
2005年 | 45篇 |
2004年 | 45篇 |
2003年 | 34篇 |
2002年 | 38篇 |
2001年 | 27篇 |
2000年 | 12篇 |
1999年 | 22篇 |
1998年 | 9篇 |
1997年 | 8篇 |
1996年 | 7篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 4篇 |
1992年 | 11篇 |
1991年 | 18篇 |
1990年 | 11篇 |
1989年 | 14篇 |
1988年 | 15篇 |
1987年 | 5篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1983年 | 2篇 |
1979年 | 5篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1970年 | 5篇 |
1969年 | 7篇 |
1968年 | 4篇 |
1967年 | 2篇 |
1966年 | 4篇 |
排序方式: 共有1338条查询结果,搜索用时 93 毫秒
41.
42.
43.
44.
45.
Matsumura T Kato T Sugiyama N Tasaka-Fujita M Murayama A Masaki T Wakita T Imawari M 《Hepatology (Baltimore, Md.)》2012,56(4):1231-1239
Because the current interferon (IFN)-based treatment for hepatitis C virus (HCV) infection has a therapeutic limitation and side effects, a more efficient therapeutic strategy is desired. Recent studies show that supplementation of vitamin D significantly improves sustained viral response via IFN-based therapy. However, mechanisms and an active molecular form of vitamin D for its anti-HCV effects have not been fully clarified. To address these questions, we infected HuH-7 cells with cell culture-generated HCV in the presence or absence of vitamin D(3) or its metabolites. To our surprise, 25-hydroxyvitamin D(3) [25(OH)D(3) ], but not vitamin D(3) or 1,25-dihydroxyvitamin D(3) , reduced the extra- and intracellular levels of HCV core antigen in a concentration-dependent manner. Single-cycle virus production assay with a CD81-negative cell line reveals that the inhibitory effect of 25(OH)D(3) is at the level of infectious virus assembly but not entry or replication. Long-term 25(OH)D(3) treatment generates a HCV mutant with acquired resistance to 25(OH)D(3) , and this mutation resulting in a N1279Y substitution in the nonstructural region 3 helicase domain is responsible for the resistance. Conclusion: 25(OH)D(3) is a novel anti-HCV agent that targets an infectious viral particle assembly step. This finding provides insight into the improved efficacy of anti-HCV treatment via the combination of vitamin D(3) and IFN. Our results also suggest that 25(OH)D(3) , not vitamin D(3) , is a better therapeutic option in patients with hepatic dysfunction and reduced enzymatic activity for generation of 25(OH)D(3) . (HEPATOLOGY 2012). 相似文献
46.
Suzuki N Yamazaki S Ema H Yamaguchi T Nakauchi H Takaki S 《Experimental hematology》2012,40(2):166-74.e3
Hematopoietic stem cells (HSCs) are maintained at a very low frequency in adult bone marrow under steady-state conditions. However, it is not fully understood how homeostasis of bone marrow HSCs is maintained. We attempted to identify a key molecule involved in the regulation of HSC numbers, a factor that, in the absence of Lnk, leads to HSC expansion. Here, we demonstrate that upon stimulation with thrombopoietin, expression of Bcl-xL, an antiapoptotic protein, was highly enhanced in Lnk-deficient HSCs compared to normal HSCs. As a result, Lnk-deficient HSCs underwent reduced apoptosis following exposure to lethal radiation. Downregulation of Bcl-xL expression in Lnk-deficient HSCs by short-hairpin RNA resulted in a great reduction of their capacity for reconstitution. These findings suggest that Lnk/Sh2b3 constrains the expression of Bcl-xL and that the loss of Lnk/Sh2b3 function enhances survival of HSCs by inhibiting apoptosis. Furthermore, our observations indicate that HSCs in patients with an Lnk/Sh2b3 mutation might become resistant to apoptosis due to thrombopoietin-mediated enhanced expression of Bcl-xL. Consequently, reduced apoptosis could facilitate accumulation of HSCs with oncogenic mutations leading to development of myeloproliferative disorders. 相似文献
47.
Shimada A Takahashi Y Muramatsu H Hama A Ismael O Narita A Sakaguchi H Doisaki S Nishio N Tanaka M Yoshida N Matsumoto K Kato K Watanabe N Kojima S 《International journal of hematology》2012,95(6):675-679
Fanconi anemia (FA) is a disorder characterized by developmental anomalies, bone marrow failure and a predisposition to malignancy. It has recently been shown that hematopoietic stem cell transplantation using fludarabine (FLU)-based reduced-intensity conditioning is an efficient and quite safe therapeutic modality. We retrospectively analyzed the outcome of bone marrow transplantation (BMT) in eight patients with FA performed in two institutes between 2001 and 2011. There were seven females and one male with a median age at diagnosis = 4.5 years (range 2-12 years). The constitutional characteristics associated with FA, such as developmental anomalies, short stature and skin pigmentation, were absent in three of the patients. One patient showed myelodysplastic features at the time of BMT. All patients received BMT using FLU, cyclophosphamide (CY) and rabbit anti-thymocyte globulin (ATG) either from a related donor (n = 4) or an unrelated donor (n = 4). Acute graft-versus-host disease (GVHD) of grade I developed in one patient, while chronic GVHD was not observed in any patient. All patients are alive and achieved hematopoietic recovery at a median follow-up of 72 months (range 4-117 months). BMT using FLU/low-dose CY/ATG -based regimens regardless to the donor is a beneficial therapeutic approach for FA patients. 相似文献
48.
Kawashima N Shimada A Taketani T Hayashi Y Yoshida N Matsumoto K Takahashi Y Kojima S Kato K 《International journal of hematology》2012,95(5):577-580
Acute myeloid leukemia with abnormal bone marrow eosinophilia (AML-M4Eo) is often reported in core binding factor (CBF) leukemia, with translocations such as inv(16)(p13q22), t(16;16)(p13;q22) or t(8;21)(q22;q22); however, it is rarely reported with t(16;21)(q24;q22), which produces the RUNX1-CBFA2T3 (AML1-MTG16) chimera. The similarity between this chimera and RUNX1-RUNXT1 (AML1-MTG8) by t(8;21)(q22;q22) remains controversial. Adult leukemia with t(16;21)(q24;q22) was primarily therapy related, and shows poor prognosis; however, pediatric AML with this translocation was quite rare and tended to be de novo AML. We present here a 4-year-old boy with de novo AML-M4Eo and t(16;21)(q24;q22). He received chemotherapy and survived for more than 70 months without transplantation. We speculated that pediatric AML with t(16;21)(q24;q22) showed favorable prognosis, as with t(8;21)(q22;q22). 相似文献
49.
50.
Kohei Kawakita Nao Shibanuma Katsumasa Tei Takayuki Nishiyama Ryosuke Kuroda Masahiro Kurosaka 《The Journal of arthroplasty》2013
We report the case of a patient with leg edema after large-diameter metal-on-metal total hip arthroplasty. At 1 year and 2 months after primary left large-diameter metal-on-metal total hip arthroplasty, the patient complained of left leg edema. At first, we suspected deep venous thrombosis. However, deep venous thrombosis was not detected by venous ultrasonographic examination. Computed tomography imaging revealed a mass in front of the iliac fossa. The mass compressed the left iliac artery and vein. We therefore believed that this lesion was the cause of the leg edema and performed resection of the mass. The resected mass consisted of necrotic tissue infiltrating inflammation cells, so it was diagnosed as pseudotumor. Unilateral leg edema disappeared gradually after the resection. 相似文献